Investors in Ovintiv Inc. (NYSE:OVV) had a good week, as its shares rose 4.0% to close at US$60.08 following the release of its second-quarter results. Revenues of US$3.0b smashed analyst forecasts, although statutory earnings came up 23% short, at US$1.62 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Following the latest results, Ovintiv's twelve analysts are now forecasting revenues of US$9.99b in 2026. This would be a credible 4.9% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to fall 15% to US$2.85 in the same period. Before this earnings report, the analysts had been forecasting revenues of US$9.43b and earnings per share (EPS) of US$3.23 in 2026. So it's pretty clear the analysts have mixed opinions on Ovintiv after the latest results; even though they upped their revenue numbers, it came at the cost of a real cut to per-share earnings expectations.

The consensus price target was unchanged at US$72.36, suggesting the business is performing roughly in line with expectations, despite some adjustments to profit and revenue forecasts. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Ovintiv, with the most bullish analyst valuing it at US$85.00 and the most bearish at US$55.00 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. One thing stands out from these estimates, which is that Ovintiv is forecast to grow faster in the future than it has in the past, with revenues expected to display 10.0% annualised growth until the end of 2026. If achieved, this would be a much better result than the 5.2% annual decline over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 3.8% annually. So it looks like Ovintiv is expected to grow faster than its competitors, at least for a while.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Ovintiv going out to 2028, and you can see them free on our platform here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.